Full-Time
Medical Assistant
Full Time-Desoto/Memphis/Brighton
Posted on 9/23/2025
West Cancer Center
51-200 employees
Provides cancer care with clinical trials
No salary listed
Arlington, TN, USA + 2 more
More locations: Memphis, TN, USA | Southaven, MS, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
- High school diploma or equivalent
- At least six (6) months of experience working in a medical facility as a Medical Assistant or similar healthcare role
- Basic Life Support (BLS) certification
- Completion of an accredited medical assisting program in lieu of the six-month experience requirement
- Proficiency with basic computer use; EMR experience preferred
- Strong written and verbal communication skills
- Ability to manage multiple tasks and maintain smooth clinic workflow
- Ability to work both independently and collaboratively as part of a care team
- Completion of required training programs within designated time frames
- Competence in motivational interviewing and teach-back techniques (or willingness to learn)
- Calm and effective response during patient emergencies
- Fulfill patient care responsibilities as directed by physicians or other clinicians
- Prepare and maintain clean, organized exam rooms, instruments, and equipment
- Assist with clinical procedures and medical documentation as needed
- Support patient flow and maintain effective communication with patients and providers
- Greet patients warmly, using their name, and maintain a professional and compassionate demeanor
- Respond quickly and appropriately in emergency situations
- Follow all clinic safety, infection control, and operational procedures
- Graduate of an accredited medical assisting program
West Cancer Center provides comprehensive cancer care with access to Phase I–III clinical trials through a partnership with Methodist Healthcare and the University of Tennessee Health Science Center. Patients receive standard cancer care and may enroll in trials, while clinicians and researchers collaborate across the lab and clinic to develop and apply new therapies. This collaboration gives patients early trial access and a lab-to-clinic workflow that ties research directly to treatment. The goal is to improve cancer outcomes by speeding up research and turning findings into effective, evidence-based therapies for patients.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Brighton, Colorado
Founded
1979
Simplify's Take
What believers are saying
- Bartlett clinic expansion adds surgical oncology services, boosting Mid-South access May 2026.
- Atlas Oncology Partners embeds value-based care teams, expanding Southeast in 2026.
- Dr. Allison Vaughn Jones joins Dermatology Clinic, enhancing skin cancer coordination May 2026.
What critics are saying
- Atlas Oncology Partners erodes fee-for-service margins via cost-risk model in 6-12 months.
- West Cancer Foundation siphons funding and loyalty, fragmenting revenues in 6-12 months.
- Shield blood test slashes colorectal screening volumes as patients adopt it in 12-18 months.
What makes West Cancer Center unique
- West Cancer Center leads Mid-South with 11 clinical campuses and Phase I-III trials.
- Founded by Dr. William H. West, it delivers world-class mesothelioma and lung cancer care.
- Partnerships with Methodist Healthcare and UTHSC enable lab-clinic synergy for patients.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
West Cancer Center news briefs. May 04, 2026 at 02:55 pm by pjeter West Cancer Center & Research Institute is pleased to announce that Dr. Allison Vaughn Jones has joined their Dermatology Multidisciplinary Clinic. Jones is a highly respected, board certified dermatologist at UT Dermatology and brings extensive experience in diagnosing and managing complex skin conditions, including those that intersect with oncology care. She will be collaborating with Dr. Jason Chandler and Dr. David Portnoy to enhance coordinated care for patients with skin cancers, treatment related dermatologic concerns, and other conditions that benefit from integrated expertise. This is a collaboration between West Cancer Center and Research Institute and the University of Tennessee Health Science Center. Jones will continue her practice at UT as the Assistant Professor of Dermatology at UTHSC, while collaborating with Dr. Portnoy. West Cancer Center & Research Institute has opened a new clinic location in Bartlett. This expansion reflects their continued commitment to increasing access to high-quality cancer care across the Mid-South. The Bartlett office will operate Monday through Thursday and will initially function as a surgery clinic. The following specialists will be providing services at the Bartlett location. Head & Neck Oncology - Dr. Richard Muller Breast Surgical Oncology - Dr. Linda Han Gynecologic Oncology - Dr. Todd Tillmanns Urogynecology - Dr. Ben Abdu Dr. Axel Grothey, medical oncologist and Director of Gastrointestinal Cancer Research at West Cancer Center & Research Institute, recently authored a powerful column in The Tennessean highlighting the urgent need for colorectal cancer screening across Tennessee. Grothey sheds light on the state's high rates of colon cancer diagnoses and deaths, while emphasizing that early detection can dramatically improve outcomes. His column also introduces a promising new FDA-approved blood test - the Shield test - which offers a more convenient, non-invasive screening option for eligible adults. Through his perspective, Grothey reinforces a critical message: one conversation with a doctor and one screening test can truly save lives. A new study published in Nature Publishing Group highlights promising strategies to improve adherence to oral endocrine therapy (AET) among younger breast cancer patients - an area critical to long-term outcomes. Dr. Gregory Vidal co-authored this important research, which examined the impact of app-based remote monitoring on treatment adherence. Findings from this randomized trial demonstrated that premenopausal women using a remote symptom-monitoring app achieved significantly higher 12-month adherence rates compared to usual care (53.9 percent vs. 25.0 percent), while no significant benefit was observed among postmenopausal patients. These results underscore the unique challenges younger patients face and highlight remote monitoring as a scalable, technology-driven approach to help close adherence gaps and improve outcomes. Link: https://www.nature.com/articles/s41523-026-00900-9
West Cancer Center and IDEOlogy Health announce strategic partnership to advance patient-centered oncology education and care. PR Newswire Today at 7:42am PDT MEMPHIS, Tenn. and AUSTIN, Texas, April 7, 2026 /PRNewswire/ - West Cancer Center & Research Institute, the Mid-South's premier provider of comprehensive adult cancer care, and IDEOlogy Health, a leader in delivering non-promotional, multi-channel medical education to oncology professionals, today announced two exclusive strategic partnership agreements designed to elevate physician and Advanced Practice Provider (APP) education. Together, these collaborations aim to strengthen oncology care delivery and improve outcomes for patients across the community. With more than 46 years of oncology expertise, 113 specialized providers, and care provided to more than 68,000 patients annually, West Cancer Center & Research Institute is a nationally recognized model for integrated cancer care. West offers advanced treatments, innovative therapies, and comprehensive patient support services, all grounded in research-driven and compassionate care. IDEOlogy Health is widely recognized for its commitment to "Creating Aha! Moments in Healthcare(R)" and for leading innovation in how healthcare professionals stay current with advancements in medicine. Through expert-led programs, roundtable discussions, and real-time clinical data updates, IDEOlogy Health empowers oncology providers with timely, relevant insights that can impact patient care from day one. A Shared Commitment to Patients This partnership reflects a shared vision between West Cancer Center & Research Institute and IDEOlogy Health: to enhance the patient journey by equipping oncology care teams with high-quality clinical education and practical tools that support exceptional, holistic care. "Our partnership with IDEOlogy Health reflects West Cancer Center & Research Institute's continued commitment to leading the region in advanced, evidence-based oncology care," said Sylvia Richey, MD, Medical Oncologist and Chief Medical Officer for West. "By expanding access to the latest clinical insights and high-quality educational resources, we are strengthening the expertise of our physicians and advanced practice providers. This collaboration further enhances our ability to deliver exceptional, patient centered care across every community we serve." By combining IDEOlogy Health's innovative educational platforms with West's deep clinical expertise, the collaboration will help accelerate the integration of emerging research into everyday clinical practice, ensuring patients benefit from the latest scientific advancements, regardless of where they receive care. "We're thrilled to partner with West Cancer Center to deliver a multi-channel medical education program tailored to the needs of its physicians and advanced practice providers," said Cameron Lush, President of IDEOlogy Health. "This partnership helps ensure care teams have timely access to the latest clinical insights to support the best possible outcomes for patients." About West Cancer Center & Research Institute West Cancer Center & Research Institute is a nationally recognized leader in adult cancer care, offering comprehensive oncology services across multiple locations in the Mid-South. With a mission rooted in research, advanced treatments, prevention, and equitable access to care, West's multidisciplinary team delivers exceptional support to patients and families throughout the entire cancer journey. About IDEOlogy Health IDEOlogy Health, part of The Lockwood Group, is leading the change in how healthcare professionals connect and stay up to date on the latest advancements in medicine. The company leverages decades of healthcare expertise and emerging technology to provide data, analysis, and educational opportunities from experts across the globe in therapeutic areas of Oncology and Hematology. SOURCE IDEOlogy Health This is a paid placement. For further inquiries, please contact PR Newswire directly.
Atlas Oncology Partners, a value-based cancer care company, has officially launched in Memphis, Tennessee, with its first partner, West Cancer Center & Research Institute. The company aims to enhance existing cancer care by embedding support teams within partner practices to guide patients through all phases of treatment. Atlas offers whole-person care coordination, psychosocial support, and management of cancer-adjacent conditions. The company's model includes onsite and virtual care teams working alongside oncologists whilst assuming full medical cost risk. Founded by President Kate Roberts and Chief Medical Officer Dr Gabrielle Rocque, Atlas plans to expand throughout the Southeast in 2026, targeting markets in Alabama, Arkansas, Louisiana, Mississippi and Texas. The company remains in pre-revenue stage whilst establishing its partnership model.
The oncologist with West Cancer Center has been named one of the 2024 Top Doctors in Memphis by the Castle Connolly research group.
- The comprehensive Cancer Care Center, in collaboration with SUNY Upstate - Development of the Auburn Heart Institute, specializing in advanced cardiovascular care - Advancements in orthopedic care services - Expansion of its operating rooms - Facility and infrastructure improvements